ATAI Life Sciences N.V’s recent filing unveils that its 10% Owner Apeiron Investment Group Ltd. acquired Company’s shares for reported $19.0 million on Aug 14 ’25. In the deal valued at $2.19 per share,8,675,799 shares were bought. As a result of this transaction, Apeiron Investment Group Ltd. now holds 51,045,214 shares worth roughly $317.5 million.
Then, SAHIL KIRPEKAR bought 83,332 shares, generating $233,830 in total proceeds.
Before that, SAHIL KIRPEKAR bought 106,093 shares. ATAI Life Sciences N.V shares valued at $294,381 were divested by the Officer at a price of $2.77 per share.
Needham initiated its ATAI Life Sciences N.V [ATAI] rating to a Buy in a research note published on October 13, 2025; the price target was $12. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. H.C. Wainwright also remained covering ATAI and reiterated its “Buy” recommendation on November 18, 2024. Maxim Group revised its rating on April 03, 2024. It rated ATAI as “a Buy” which previously was an “a Hold”.
Price Performance Review of ATAI
On Monday, ATAI Life Sciences N.V [NASDAQ:ATAI] saw its stock jump 7.80% to $6.22. Over the last five days, the stock has lost -3.12%. ATAI Life Sciences N.V shares have risen nearly 414.05% since the year began. Nevertheless, the stocks have risen 367.67% over the past one year. While a 52-week high of $6.75 was reached on 10/20/25, a 52-week low of $1.04 was recorded on 04/09/25.
Levels Of Support And Resistance For ATAI Stock
The 24-hour chart illustrates a support level at 5.98, which if violated will result in even more drops to 5.73. On the upside, there is a resistance level at 6.35. A further resistance level may holdings at 6.47.
How much short interest is there in ATAI Life Sciences N.V?
A steep rise in short interest was recorded in ATAI Life Sciences N.V stocks on 2025-10-15, dropping by -1.67 million shares to a total of 16.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 17.79 million shares. There was a decline of -10.35%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 01, 2022 when Loop Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
